Global Rivaroxaban Market Research Report 2017

Publisher Name :
Date: 10-Nov-2017
No. of pages: 104
Inquire Before Buying

In this report, the global Rivaroxaban market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Rivaroxaban in these regions, from 2012 to 2022 (forecast), covering

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Global Rivaroxaban market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

- Bayer

- J&J

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- 2.5 mg

- 10 mg

- 15 mg

- 20 mg

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Rivaroxaban for each application, including

- Acute coronary syndrome (ACS)

- Venous thromboembolism (VTE)

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Rivaroxaban Market Research Report 2017

Table of Contents
Global Rivaroxaban Market Research Report 2017
1 Rivaroxaban Market Overview
1.1 Product Overview and Scope of Rivaroxaban
1.2 Rivaroxaban Segment by Type (Product Category)
1.2.1 Global Rivaroxaban Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Rivaroxaban Production Market Share by Type (Product Category) in 2016
1.2.3 2.5 mg
1.2.4 10 mg
1.2.5 15 mg
1.2.6 20 mg
1.3 Global Rivaroxaban Segment by Application
1.3.1 Rivaroxaban Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Acute coronary syndrome (ACS)
1.3.3 Venous thromboembolism (VTE)
1.4 Global Rivaroxaban Market by Region (2012-2022)
1.4.1 Global Rivaroxaban Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Rivaroxaban (2012-2022)
1.5.1 Global Rivaroxaban Revenue Status and Outlook (2012-2022)
1.5.2 Global Rivaroxaban Capacity, Production Status and Outlook (2012-2022)
2 Global Rivaroxaban Market Competition by Manufacturers
2.1 Global Rivaroxaban Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Rivaroxaban Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Rivaroxaban Production and Share by Manufacturers (2012-2017)
2.2 Global Rivaroxaban Revenue and Share by Manufacturers (2012-2017)
2.3 Global Rivaroxaban Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Rivaroxaban Manufacturing Base Distribution, Sales Area and Product Type
2.5 Rivaroxaban Market Competitive Situation and Trends
2.5.1 Rivaroxaban Market Concentration Rate
2.5.2 Rivaroxaban Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Rivaroxaban Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Rivaroxaban Capacity and Market Share by Region (2012-2017)
3.2 Global Rivaroxaban Production and Market Share by Region (2012-2017)
3.3 Global Rivaroxaban Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Rivaroxaban Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Rivaroxaban Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Rivaroxaban Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Rivaroxaban Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Rivaroxaban Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Rivaroxaban Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Rivaroxaban Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
4 Global Rivaroxaban Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Rivaroxaban Consumption by Region (2012-2017)
4.2 North America Rivaroxaban Production, Consumption, Export, Import (2012-2017)
4.3 Europe Rivaroxaban Production, Consumption, Export, Import (2012-2017)
4.4 China Rivaroxaban Production, Consumption, Export, Import (2012-2017)
4.5 Japan Rivaroxaban Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Rivaroxaban Production, Consumption, Export, Import (2012-2017)
4.7 India Rivaroxaban Production, Consumption, Export, Import (2012-2017)
5 Global Rivaroxaban Production, Revenue (Value), Price Trend by Type
5.1 Global Rivaroxaban Production and Market Share by Type (2012-2017)
5.2 Global Rivaroxaban Revenue and Market Share by Type (2012-2017)
5.3 Global Rivaroxaban Price by Type (2012-2017)
5.4 Global Rivaroxaban Production Growth by Type (2012-2017)
6 Global Rivaroxaban Market Analysis by Application
6.1 Global Rivaroxaban Consumption and Market Share by Application (2012-2017)
6.2 Global Rivaroxaban Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Rivaroxaban Manufacturers Profiles/Analysis
7.1 Bayer
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Rivaroxaban Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Bayer Rivaroxaban Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 J&J
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Rivaroxaban Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 J&J Rivaroxaban Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
8 Rivaroxaban Manufacturing Cost Analysis
8.1 Rivaroxaban Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Rivaroxaban
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Rivaroxaban Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Rivaroxaban Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Rivaroxaban Market Forecast (2017-2022)
12.1 Global Rivaroxaban Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Rivaroxaban Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Rivaroxaban Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Rivaroxaban Price and Trend Forecast (2017-2022)
12.2 Global Rivaroxaban Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Rivaroxaban Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Rivaroxaban Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Rivaroxaban Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Rivaroxaban Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Rivaroxaban Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Rivaroxaban Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Rivaroxaban Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Rivaroxaban Consumption Forecast by Application (2017-2022)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Rivaroxaban
Figure Global Rivaroxaban Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Rivaroxaban Production Market Share by Types (Product Category) in 2016
Figure Product Picture of 2.5 mg
Table Major Manufacturers of 2.5 mg
Figure Product Picture of 10 mg
Table Major Manufacturers of 10 mg
Figure Product Picture of 15 mg
Table Major Manufacturers of 15 mg
Figure Product Picture of 20 mg
Table Major Manufacturers of 20 mg
Figure Global Rivaroxaban Consumption (K Units) by Applications (2012-2022)
Figure Global Rivaroxaban Consumption Market Share by Applications in 2016
Figure Acute coronary syndrome (ACS) Examples
Table Key Downstream Customer in Acute coronary syndrome (ACS)
Figure Venous thromboembolism (VTE) Examples
Table Key Downstream Customer in Venous thromboembolism (VTE)
Figure Global Rivaroxaban Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Rivaroxaban Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Rivaroxaban Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Rivaroxaban Major Players Product Capacity (K Units) (2012-2017)
Table Global Rivaroxaban Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Rivaroxaban Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Rivaroxaban Capacity (K Units) of Key Manufacturers in 2016
Figure Global Rivaroxaban Capacity (K Units) of Key Manufacturers in 2017
Figure Global Rivaroxaban Major Players Product Production (K Units) (2012-2017)
Table Global Rivaroxaban Production (K Units) of Key Manufacturers (2012-2017)
Table Global Rivaroxaban Production Share by Manufacturers (2012-2017)
Figure 2016 Rivaroxaban Production Share by Manufacturers
Figure 2017 Rivaroxaban Production Share by Manufacturers
Figure Global Rivaroxaban Major Players Product Revenue (Million USD) (2012-2017)
Table Global Rivaroxaban Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Rivaroxaban Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Rivaroxaban Revenue Share by Manufacturers
Table 2017 Global Rivaroxaban Revenue Share by Manufacturers
Table Global Market Rivaroxaban Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Rivaroxaban Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Rivaroxaban Manufacturing Base Distribution and Sales Area
Table Manufacturers Rivaroxaban Product Category
Figure Rivaroxaban Market Share of Top 3 Manufacturers
Figure Rivaroxaban Market Share of Top 5 Manufacturers
Table Global Rivaroxaban Capacity (K Units) by Region (2012-2017)
Figure Global Rivaroxaban Capacity Market Share by Region (2012-2017)
Figure Global Rivaroxaban Capacity Market Share by Region (2012-2017)
Figure 2016 Global Rivaroxaban Capacity Market Share by Region
Table Global Rivaroxaban Production by Region (2012-2017)
Figure Global Rivaroxaban Production (K Units) by Region (2012-2017)
Figure Global Rivaroxaban Production Market Share by Region (2012-2017)
Figure 2016 Global Rivaroxaban Production Market Share by Region
Table Global Rivaroxaban Revenue (Million USD) by Region (2012-2017)
Table Global Rivaroxaban Revenue Market Share by Region (2012-2017)
Figure Global Rivaroxaban Revenue Market Share by Region (2012-2017)
Table 2016 Global Rivaroxaban Revenue Market Share by Region
Figure Global Rivaroxaban Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Rivaroxaban Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Rivaroxaban Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Rivaroxaban Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Rivaroxaban Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Rivaroxaban Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Rivaroxaban Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Rivaroxaban Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Rivaroxaban Consumption (K Units) Market by Region (2012-2017)
Table Global Rivaroxaban Consumption Market Share by Region (2012-2017)
Figure Global Rivaroxaban Consumption Market Share by Region (2012-2017)
Figure 2016 Global Rivaroxaban Consumption (K Units) Market Share by Region
Table North America Rivaroxaban Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Rivaroxaban Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Rivaroxaban Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Rivaroxaban Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Rivaroxaban Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Rivaroxaban Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Rivaroxaban Production (K Units) by Type (2012-2017)
Table Global Rivaroxaban Production Share by Type (2012-2017)
Figure Production Market Share of Rivaroxaban by Type (2012-2017)
Figure 2016 Production Market Share of Rivaroxaban by Type
Table Global Rivaroxaban Revenue (Million USD) by Type (2012-2017)
Table Global Rivaroxaban Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Rivaroxaban by Type (2012-2017)
Figure 2016 Revenue Market Share of Rivaroxaban by Type
Table Global Rivaroxaban Price (USD/Unit) by Type (2012-2017)
Figure Global Rivaroxaban Production Growth by Type (2012-2017)
Table Global Rivaroxaban Consumption (K Units) by Application (2012-2017)
Table Global Rivaroxaban Consumption Market Share by Application (2012-2017)
Figure Global Rivaroxaban Consumption Market Share by Applications (2012-2017)
Figure Global Rivaroxaban Consumption Market Share by Application in 2016
Table Global Rivaroxaban Consumption Growth Rate by Application (2012-2017)
Figure Global Rivaroxaban Consumption Growth Rate by Application (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Rivaroxaban Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Rivaroxaban Production Growth Rate (2012-2017)
Figure Bayer Rivaroxaban Production Market Share (2012-2017)
Figure Bayer Rivaroxaban Revenue Market Share (2012-2017)
Table J&J Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table J&J Rivaroxaban Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure J&J Rivaroxaban Production Growth Rate (2012-2017)
Figure J&J Rivaroxaban Production Market Share (2012-2017)
Figure J&J Rivaroxaban Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rivaroxaban
Figure Manufacturing Process Analysis of Rivaroxaban
Figure Rivaroxaban Industrial Chain Analysis
Table Raw Materials Sources of Rivaroxaban Major Manufacturers in 2016
Table Major Buyers of Rivaroxaban
Table Distributors/Traders List
Figure Global Rivaroxaban Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Rivaroxaban Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Rivaroxaban Price (Million USD) and Trend Forecast (2017-2022)
Table Global Rivaroxaban Production (K Units) Forecast by Region (2017-2022)
Figure Global Rivaroxaban Production Market Share Forecast by Region (2017-2022)
Table Global Rivaroxaban Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Rivaroxaban Consumption Market Share Forecast by Region (2017-2022)
Figure North America Rivaroxaban Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Rivaroxaban Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Rivaroxaban Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Rivaroxaban Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Rivaroxaban Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Rivaroxaban Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Rivaroxaban Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Rivaroxaban Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Rivaroxaban Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Rivaroxaban Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Rivaroxaban Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Rivaroxaban Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Rivaroxaban Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Rivaroxaban Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Rivaroxaban Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Rivaroxaban Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Rivaroxaban Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Rivaroxaban Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Rivaroxaban Production (K Units) Forecast by Type (2017-2022)
Figure Global Rivaroxaban Production (K Units) Forecast by Type (2017-2022)
Table Global Rivaroxaban Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Rivaroxaban Revenue Market Share Forecast by Type (2017-2022)
Table Global Rivaroxaban Price Forecast by Type (2017-2022)
Table Global Rivaroxaban Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Rivaroxaban Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
  • 2018-2023 Global Anti-Infective Drugs Consumption Market Report
    Published: 15-Oct-2018        Price: US 4660 Onwards        Pages: 164
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Anti-Infective Drugs market for 2018-2023. Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals. Over the next five years, LPI(LP Infor......
  • Global Dengue Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Oct-2018        Price: US 3480 Onwards        Pages: 129
    The Aedes aegypti mosquito is responsible for transmitting the dengue virus (DENV). The virus that causes dengue belongs to the Flavivirus genus of the Flaviviridae family. Dengue fever resembles influenza and affects adults, children, as well as infants, but it is rarely fatal. However, dengue hemorrhagic fever is a potentially fatal complication because of multiple factors such as fluid accumulation, severe bleeding, organ impairment, or plasma leaking. Scope of the Report:......
  • Global and United States Hyperphosphatemia Drugs Market Research by Company, Type & Application 2013-2025
    Published: 14-Oct-2018        Price: US 2000 Onwards        Pages: 107
    Summary Market Segment as follows: By Type - Aluminum Phosphate Binder - Iron Phosphate Binder - Magnesium Phosphate Binder - Calcium Phosphate Binder By Application - Hospitals - Clinics - Others By Company - Shire - Keryx Biopharmaceuticals - Sanofi - Fresenius Medical Care - Vifor Pharma - Kyowa Hakko Kirin - Japan Tobacco - Tori......
  • Global and United States Corticosteroids Market Research by Company, Type & Application 2013-2025
    Published: 13-Oct-2018        Price: US 2000 Onwards        Pages: 95
    Summary Market Segment as follows: By Type - Cream - Injection - Others By Application - Hospital - Clinic - Others By Company - Sumitomo - Pfizer - Novartis - Merck - Sanofi - Johnson and Johnson - GSK - AstraZeneca - Cipla The main contents of the report including: Section 1: Product definition, type and app......
  • Global and United States Albendazole Market Research by Company, Type & Application 2013-2025
    Published: 13-Oct-2018        Price: US 2000 Onwards        Pages: 98
    Summary Market Segment as follows: By Type - Capsule - Tablet By Application - Pinworm Infection Treatment - Ascaris Infection Treatment - Other Parasitic Infections Treatment By Company - CHANGZHOU YABANG - GlaxoSmithKline - Huazhong Pharmaceutical - Hubei Zhongjia-chem Pharmaceutical - HUBEI KEYI - Sequent Scientifi - Lasa Laboratory Pvt Ltd - ......
  • Global and United States Benign Prostatic Hyperplasia (BPH) Drugs Market Research by Company, Type & Application 2013-2025
    Published: 13-Oct-2018        Price: US 2000 Onwards        Pages: 105
    Summary Market Segment as follows: By Type - Alpha-blocker - Phosphodiesterase Type-5 Inhibitors - 5-alpha-Reductase Inhibitors By Application - Hospitals - Clinics - Others By Company - Astellas Pharma - Eli Lilly - GlaxoSmithKline - Sanofi - ADC Therapeutics - Bayer HealthCare - Bristol-Myers Squibb - Valeant Pharmaceuticals - End......
  • Global DNA Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 12-Oct-2018        Price: US 3480 Onwards        Pages: 133
    A DNA vaccine is a small, circular DNA plasmid that encode one or more protein antigens under the control of a promoter to produce immune response against disease. DNA vaccines are basically the third generation vaccines that are specifically designed to overcome the unsought properties of conventional vaccines. Scope of the Report: This report focuses on the DNA Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and ......
  • Global Flu Vaccine Market Insights, Forecast to 2025
    Published: 12-Oct-2018        Price: US 3900 Onwards        Pages: 117
    In 2017, the global Flu Vaccine market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Flu Vaccine market based on company, product type, application and key regions. This report studies the global market size of Flu Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumptio......
  • 2018-2023 Global Pneumonia Vaccine Consumption Market Report
    Published: 11-Oct-2018        Price: US 6990 Onwards        Pages: 136
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Pneumonia Vaccine market for 2018-2023. Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines. Over the next five years, LP......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs